<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000527374"><TermName>MORAb-009</TermName><TermDefinition><DefinitionText>A substance being studied in the treatment of mesothelioma. MORAb-009 binds to a protein called mesothelin, which is found on some cancer cells. MORAb-009 may help the immune system kill cancer cells. It is a type of monoclonal antibody. Also called amatuximab and anti-mesothelin monoclonal antibody MORAb-009.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>MORAb-009</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del mesotelioma. MORAb-009 se une a una proteína llamada mesotelina, que se encuentra en algunas células cancerosas. MORAb-009 podría ayudar al sistema inmunitario a destruir células cancerosas. Es un tipo de anticuerpo monoclonal. También se llama amatuximab y anticuerpo monoclonal MORAb-009 anti mesotelina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-04-13</DateFirstPublished><DateLastModified>2014-03-10</DateLastModified></GlossaryTerm>
